(Q35120911)

6 August 2017

title

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer (English)

1 reference

6 August 2017

1 reference

20

Mehmet Toner

1 reference

6 August 2017

21

Daniel A Haber

1 reference

6 August 2017

19

Lecia V Sequist

1 reference

6 August 2017

22

Shyamala Maheswaran

1 reference

6 August 2017

5

David T Miyamoto

1 reference

6 August 2017

12

Dina I Tsukrov

1 reference

6 August 2017

6

Lindsey Ulkus

1 reference

6 August 2017

11

Alessandra L Moore

1 reference

6 August 2017

8

Matthew Ulman

1 reference

6 August 2017

1

Shannon L Stott

1 reference

6 August 2017

Richard J Lee

2

1 reference

6 August 2017

Sunitha Nagrath

3

1 reference

6 August 2017

Min Yu

4

1 reference

6 August 2017

Elizabeth J Inserra

7

1 reference

6 August 2017

Simeon Springer

9

1 reference

6 August 2017

Zev Nakamura

10

1 reference

6 August 2017

Maria E Kempner

13

1 reference

6 August 2017

Douglas M Dahl

14

1 reference

6 August 2017

Chin-Lee Wu

15

1 reference

6 August 2017

A John Iafrate

16

1 reference

6 August 2017

Matthew R Smith

17

1 reference

6 August 2017

Ronald G Tompkins

18

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Science Translational Medicine

6 August 2017

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

25

1 reference

6 August 2017

page(s)

25ra23

1 reference

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Screening and prostate-cancer mortality in a randomized European study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Mortality results from a randomized prostate-cancer screening trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Detection of mutations in EGFR in circulating lung-cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

28 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Isolation of rare circulating tumour cells in cancer patients by microchip technology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Identification and characterization of circulating prostate carcinoma cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141292

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000403

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status

21 January 2018

1 reference

12 December 2020

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

1 reference

12 December 2020

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity

1 reference

12 December 2020

Circulating tumor cells predict survival in patients with metastatic prostate cancer

1 reference

12 December 2020

Circulating tumor cells in patients with breast cancer dormancy

1 reference

12 December 2020

Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival

1 reference

12 December 2020

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer

1 reference

12 December 2020

10.1126/SCITRANSLMED.3000403

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference